| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/1991 | US5036071 Derivatives of purine |
| 07/30/1991 | US5036069 Anthelmintic active compound combinations |
| 07/30/1991 | US5036068 4-(pyridyl)- and 4-(oxo-pyridyl)-1,3-benzoxazines |
| 07/30/1991 | US5036066 Tricyclic pyridine derivatives |
| 07/30/1991 | US5036065 Benzothiadiazepine derivatives |
| 07/30/1991 | US5036064 Cephalosporins with sulfur-containing oxyimino side chain |
| 07/30/1991 | US5036063 Penicillins substituted with cyclobutyl group |
| 07/30/1991 | US5036062 Antitumor |
| 07/30/1991 | US5036060 Antitumor agent, lyophilized formulation containing sodium chloride as excipient |
| 07/30/1991 | US5036059 1,4-Dihydropyridine-3-carboxylate derivatives |
| 07/30/1991 | US5036058 N-substituted aminoalkanediphosphonic acids |
| 07/30/1991 | US5036055 Antitumor agents, treatment of leukemia |
| 07/30/1991 | US5036053 Diol-containing renin inhibitors |
| 07/30/1991 | US5036046 Method for enhancing healing of corneal endothelial wounds |
| 07/30/1991 | US5035899 Benzimidazole antiulcer agents, protective coatings on tablets, stabilization |
| 07/30/1991 | US5035895 Vitamins, phosphatides, polyhydric alcohol, amino acid |
| 07/30/1991 | US5035891 Sustained release of animal growth promoters for livestock, anticancer agents for humans |
| 07/30/1991 | US5035882 Piperine, cough medicine, mouth washes, toostepastes |
| 07/30/1991 | US5035878 Reversing bone marrow damage resulting from chemotherapy |
| 07/30/1991 | CA2035086A1 Skin care compositions |
| 07/30/1991 | CA1287061C Pyridine ethanolamine derivatives |
| 07/30/1991 | CA1287060C Crystalline paroxetine hcl |
| 07/30/1991 | CA1287059C Bis-triazole derivatives having antifungal activity |
| 07/30/1991 | CA1287052C Pyrimido[5,4-b][1,4]oxazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 07/30/1991 | CA1287050C Antiviral purine derivatives |
| 07/30/1991 | CA1287049C Nitrofuran derivatives, their preparation and compositions containing them |
| 07/30/1991 | CA1286992C Pharmaceutical composition with analgesic activity |
| 07/30/1991 | CA1286991C Medicament for the treatment of virus infections |
| 07/30/1991 | CA1286990C Nutritional supplement for treatment of uremia |
| 07/27/1991 | WO1991011453A2 5-oxygenated-2,4,6-triaminopyrimidines |
| 07/27/1991 | WO1991011440A1 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient |
| 07/27/1991 | WO1991011187A1 Pharmaceutical formulation |
| 07/27/1991 | WO1991011182A1 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis |
| 07/27/1991 | CA2073028A1 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis |
| 07/27/1991 | CA2071000A1 5-oxygenated-2,4,6-triaminopyrimidines |
| 07/27/1991 | CA2034955A1 Dietary food for patients with renal insufficiency |
| 07/27/1991 | CA2032898A1 Method for treating cardiovascular diseases, e.g. myocardial ischemia and ventricular arrhythmia is enclosed |
| 07/26/1991 | CA2034861A1 N-myristoyl-(s)-phenylalanine for the production of drugs used in the treatment of illnesses by myristoylation |
| 07/25/1991 | WO1991010743A1 Glycoalkaloids |
| 07/25/1991 | WO1991010671A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/25/1991 | WO1991010666A1 Three new non-polyglutamatable deazaaminopterins and process for preparing the same |
| 07/25/1991 | WO1991010649A1 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 07/25/1991 | WO1991010639A1 New intermediates, their production and use |
| 07/25/1991 | WO1991010442A1 Hiv protease inhibitors |
| 07/25/1991 | WO1991010437A1 Methods of enhancing wound healing and tissue repair |
| 07/25/1991 | WO1991010434A1 A medicament comprising methylcellulose or hydroxyalkyl methylcellulose, and use thereof |
| 07/25/1991 | WO1991010431A1 Fat emulsion |
| 07/25/1991 | WO1991010430A1 Esters of 2-arylmethyl-1-naphthol derivatives as 5-lipoxygenase inhibitors |
| 07/25/1991 | WO1991010427A2 The effect of transglutaminase inhibition on microfilariae development and macrofilariae viability |
| 07/25/1991 | WO1991010426A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/25/1991 | WO1991010421A1 Use of n-acyl derivatives of homocysteine to modify the structure of keratin and cosmetic compositions containing these derivatives |
| 07/25/1991 | WO1991010419A1 Hair tonic and dressing composition |
| 07/25/1991 | WO1991009020A3 Production of 5-(4'-hydroxyphenyl)hydantoin and d-p-hydroxyphenylglycine from 4-hydroxyacetophenone |
| 07/25/1991 | DE4001623A1 Use of known 5-pyridazinyl-benzimidazole derivs. - for treatment of acute or chromic obstructive respiratory disorders e.g. asthma bronchitis etc. |
| 07/24/1991 | EP0438311A2 Di- and tripeptide renin inhibitors |
| 07/24/1991 | EP0438259A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/24/1991 | EP0438249A1 Controlled absorption naproxen formulation for once-daily administration |
| 07/24/1991 | EP0438234A1 Antithrombin solution and use thereof |
| 07/24/1991 | EP0438233A2 Orally active renin inhibitors |
| 07/24/1991 | EP0438230A2 Indole-substituted five-membered heteroaromatic compounds |
| 07/24/1991 | EP0438223A1 N-(2-oxoazacycloalkyl) glutarylamide derivatives and their use as collagenase inhibitors |
| 07/24/1991 | EP0438206A1 6-Ring-containing macrocyclic tetraaza compounds, processes for their preparation, and pharmaceutical agents containing them |
| 07/24/1991 | EP0438183A1 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 07/24/1991 | EP0438146A2 Interleukin-1-beta for treating ulcers |
| 07/24/1991 | EP0438091A2 Freeze-dried preparation of etoposide-2-dimethylamino compound |
| 07/24/1991 | EP0437929A2 Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease |
| 07/24/1991 | EP0437846A2 Solutions of decaplanin salts, their preparation and their use, as well as crystalline decaplanin salts, their preparation and their use |
| 07/24/1991 | EP0437820A2 Process for the preparation of glycosyl-anthracyclinones |
| 07/24/1991 | EP0437799A1 The diastereoselective preparation of phosphinate esters |
| 07/24/1991 | EP0437790A2 Antithrombotic compounds |
| 07/24/1991 | EP0437694A1 Use of a hydroxyoctadécadiene acid, its keto-oxydized acid and their derivatives in the treatment of estrogen-dependent diseases, and pharmaceutical compositions thereof |
| 07/24/1991 | EP0437645A1 Imidazolylpropylguanidine-derivative, process for its preparation and medicaments containing it |
| 07/24/1991 | EP0437552A1 Alkyl derivates in 17/21 of 19-nor progesterone |
| 07/24/1991 | EP0437527A1 Nucleoside derivatives |
| 07/24/1991 | EP0437524A1 Triglyceride and nutritional composition comprising such triglycerides. |
| 07/24/1991 | EP0437523A1 Triglycerides, nutritional composition comprising such triglycerides, and use of the nutritional composition for nutrition. |
| 07/24/1991 | EP0437522A1 Emulsion and use of the emulsion as a parenteral preparation |
| 07/24/1991 | EP0437521A1 Emulsion and use of the emulsion as a parenteral preparation |
| 07/24/1991 | EP0437520A1 Triglyceride and nutritional composition comprising such triglyceride. |
| 07/24/1991 | EP0437519A1 Triglycerides and nutritional composition comprising such triglycerides. |
| 07/24/1991 | EP0437518A1 Triglycerides and composition comprising such triglycerides. |
| 07/24/1991 | EP0437508A1 Non-peptide renin inhibitors |
| 07/24/1991 | EP0437469A1 Nucleoside derivatives |
| 07/24/1991 | EP0380647A4 Compositions and in situ methods for forming films on body tissue |
| 07/24/1991 | EP0284612B1 Treatment of bone loss |
| 07/24/1991 | EP0231367B1 Use of oxirancarboxylic acids for the treatment of hyperlipemia |
| 07/24/1991 | CN1053239A Production of glycosides, especially of steroidal glycosides |
| 07/24/1991 | CN1053238A Morpholinyl derivatives of doxorubicin and process for their prepn. |
| 07/24/1991 | CN1053231A Cyclic amine compounds and their use |
| 07/24/1991 | CN1053230A Process for prepn. of ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 07/24/1991 | CN1053185A Injectable solution and process for preparing same |
| 07/24/1991 | CN1053183A Stable oral zinc compound |
| 07/24/1991 | CN1013274B Prepn. of cephalosporin derivatives |
| 07/24/1991 | CA2033682A1 3-l-(5-thioxo-l-propyl)thiazolidine-4-carboxylic acid and derivatives therefrom, processes for the preparation thereof and pharmaceutical compositions containing them |
| 07/24/1991 | CA2008519A1 Method for the inhibition of cell-cell and cell-substratum interactions by the blocking of carbohydrate-carbohydrate interactions |
| 07/23/1991 | WO1991010428A1 Drugs and use thereof |
| 07/23/1991 | US5034553 Platinum-(II)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action which contains this compound and also shaped preparations with an anti-tumour action |
| 07/23/1991 | US5034539 Histamine derivative, process for preparing it and its therapeutic use |
| 07/23/1991 | US5034530 Imidazoquinoxaline compounds and their preparation and use |
| 07/23/1991 | US5034528 1,3,5-triazabicyclo 3.1.0!hexane-3,5-diones |